Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH) is Drug Discovery in Malaysia that focus on developer business. They cover business area such as developer, biopharmaceutical drug, affordability, accessibility, healthcare, research, production, biosimilar drug.
-
Developer
-
Cyberjaya, Selangor
Malaysia
Private
developerbiopharmaceutical drugaffordabilityaccessibilityhealthcareresearchproductionbiosimilar drug
* We use standard office opening hours in near Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH) is Drug Discovery business from Malaysia that founded in - ( years old in ), Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH) business is focusing on Developer.
Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH) headquarter office and corporate office address is located in Cyberjaya, Selangor Malaysia.
Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH) was founded in Malaysia.
In , Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH) is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Biosimilar Production Facility (Duopharma Biotech / PanGen Biotech / VentureTECH), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
